SCHEMBL7349361

SCHEMBL7349361

O=C(N[C@@H](CS)C(=O)NCc1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTRB1 P17538 1/20 0.56
▸ CTSL P07711 2/20 0.56
▸ CTSS P25774 1/20 0.56
▸ CTSK P43235 1/20 0.56
▸ FNTA P49354 4/20 0.53
▸ FNTB P49356 4/20 0.53
▸ KDM1A O60341 5/20 0.53
▸ KDM1B Q8NB78 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ KMT2A Q03164 1/20 0.52
▸ CA12 O43570 1/20 0.51
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ CA3 P07451 1/20 0.51
▸ CA4 P22748 1/20 0.51
▸ CA6 P23280 1/20 0.51
▸ CA5A P35218 1/20 0.51
▸ CA7 P43166 1/20 0.51
▸ CACNA1C Q13936 1/20 0.51
▸ SCN9A Q15858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14279166 0.89 KDM1A (0.56) CTRB1CTSLCTSSCTSKKDM1A
SCHEMBL13490155 0.84 MME (0.56) CTRB1CTSLCTSSCTSKKMT2A
SCHEMBL7356728 0.84 CA12 (0.72) CTSSCTSKFNTAFNTBKMT2A
SCHEMBL11780493 0.81 CTSL (0.73) CTSLCTSSCTSKKMT2AKLKB1
SCHEMBL15764565 0.81 KDM1A (0.63) CTSLCTSSCTSKKDM1AKDM1B
SCHEMBL16155821 0.81 KDM1A (0.63) CTSLCTSSCTSKKDM1AKDM1B
SCHEMBL17531099 0.80 KDM1A (0.62) CTSLCTSSCTSKKDM1AKDM1B
SCHEMBL15764569 0.80 GRIN1 (0.63) KDM1AKDM1BCA1CA2
SCHEMBL17133692 0.80 GRIN1 (0.63) KDM1AKDM1BCA1CA2
SCHEMBL3447634 0.79 CA2 (0.65) CTRB1FNTAFNTBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1034163-A1 NEW CYSTEINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION, AND PHARMACEUTICALS CONTAINING THEM Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin (DE) 2000-09-13 — — EP disclosed
WO-1998050351-A1 NEW CYSTEINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION, AND PHARMACEUTICALS CONTAINING THEM Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Berlin (DE) 1998-11-12 — — WO disclosed
Send feedback